Abstract
Autistic disorder (AD) is a complex neuropsychiatric disorder of neurodevelopmental origin, where multiple genetic and environmental factors may interact, resulting in a clinical continuum. The genetic component is best described by a multilocus model that takes into account epistatic interactions between several susceptibility genes. In the past ten years enormous progress has been made in identifying chromosomal regions in linkage with AD, but moving from chromosomal regions to candidate genes has proven to be tremendously difficult. Neuroanatomical findings point to early dysgenetic events taking place in the cerebral cortex, cerebellum, and brainstem. At the cellular level, disease mechanisms may include altered cell migration, increased cell proliferation, decreased cell death, or altered synapse elimination. Neurochemical findings in AD point to involvement of multiple neurotransmitter systems. The serotoninergic system has been intensively investigated in AD, but other neurotransmitter systems (e.g., the GABAergic and the cholinergic system) are also coming under closer scrutiny. The role of environmental factors is still poorly characterized. It is not clear yet whether environmental factors act merely as precipitating agents, always requiring an underlying genetic liability, or whether they represent an essential component of a pathogenetic process where genetic liability alone does not lead to the full-blown autism phenotype. A third potential player in the pathogenesis of autism, in addition to genetic and environmental factors, is developmental variability due to “random” factors, e.g. small fluctuations of gene expression and complex, non-deterministic interactions between genes during brain development. These considerations suggest that a non-deterministic conceptual framework is highly appropriate for autism research.
Similar content being viewed by others
References
American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th Edition.
Kanner, L. (1943) Autistic disturbances of affective contact. Nervous Child 2, 217–250.
Asperger, H. (1944) Die “autistischen Psychopathen” im Kindesalter. Archiv für Psychiatrie und Nervenkrankheiten 117, 76–136.
Frith, U. (1991) Autism and Asperger syndrome, Cambridge University Press, Cambridge, UK.
Wing, L. (1981) Asperger’s syndrome: a clinical account. Psychol. Med. 11, 115–129.
Lord, C. and Schopler, E. (1988) in Diagnosis and Assessment in Autism (Schopler, E. and Mesibov, G., eds.), pp. 167–181, Plenum Press, New York.
Bienvenu, T., Poirier, K., Friocourt, G., et al. (2002) ARX, a novel Prd-class-homeobox gene highly expressed in the telencephalon, is mutated in X-linked mental retardation. Hum. Mol. Genet. 11, 981–991.
Chakrabarti, S. and Fombonne, E. (2001) Pervasive developmental disorders in preschool children. J. Am. Med. Associat. 285, 3093–3099.
Fombonne, E. (2001) Is there an epidemic of autism? Pediatrics 107, 411–412.
Madsen, K. M., Hviid, A., Vestergaard, M., Schendel, D., Wohlfahrt, J., Thorsen, P., Olsen, J., and Melbye, M. (2002) A population-based study of measles, mumps, and rubella vaccination and autism. New Engl. J. Med. 347, 1477–1482.
Miles, J. H., Hadden, L. L., Takahashi, T. N., and Hillman, R. E. (2000) Head circumference is an independent clinical finding associated with autism. Am. J. Med. Genet. 95, 339–350.
Wing, L. (1997) The autistic spectrum. Lancet 350, 1761–1766.
Miles, J. H. and Hillman, R. E. (2000) Value of a clinical morphology examination in autism. Am. J. Med. Genet. 91, 245–253.
Smalley, S. L. (1997) Genetic influences in childhood-onset psychiatric disorders: autism and attention-deficit/hyperactivity disorder. Am. J. Hum. Genet. 60, 1276–1282.
Davidovitch, M., Glick, L., Holtzman, G., Tirosh, E., and Safir, M. P. (2000) Developmental regression in autism: maternal perception. J. Autism Dev. Disord. 30, 113–119.
Rapin, I. (1995) Autistic regression and disintegrative disorder: how important the role of epilepsy? Semin. Pediatr. Neurol. 2, 278–285.
Shinnar, S., Rapin, I., Arnold, S., Tuchman, R. F., Shulman, L., Ballaban-Gil, K., Maw, M., Deuel, R. K., and Volkmar, F. R. (2001) Language regression in childhood. Pediatr. Neurol. 24, 183–189.
Rapin, I. and Katzman, R. (1998) Neurobiology of autism. Ann. Neurol. 43, 7–14.
Wakefield, A. J., Murch, S. H., Anthony, A., et al. (1998) Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 351, 637–641.
Folstein, S. E. and Rosen-Sheidley, B. (2001) Genetics of autism: complex aetiology for a heterogeneous disorder. Nat. Rev. Genet. 2, 943–955.
McAdams, H. H. and Arkin, A. (1999) It’s a noisy business! Genetic regulation at the nanomolar scale. Trends Genetics 15, 65–69.
McAdams, H. H. and Arkin, A. (1997) Stochastic mechanisms in gene expression. Proc. Natl. Acad. Sci. USA 94, 814–819.
Fedoroff, N. and Fontana, W. (2002) Genetic networks. Small numbers of big molecules. Science 297, 1129–1131.
Brody, S. L., Yan, X. H., Wuerffel, M. K., Song, S. K., and Shapiro, S. D. (2000) Ciliogenesis and left-right axis defects in forkhead factor HFH-4-null mice. Am. J. Respir. Cell. Mol. Biol. 23, 45–51.
Ghaziuddin, M., Zaccagnini, J., Tsai, L., and Elardo, S. (1999) Is megalencephaly specific to autism? J. Intell. Disab. Res. 43, 279–282.
Hardan, A. Y., Minshew, N., Mallikarjuhn, M., and Keshavan, M. S. (2001) Brain volume in autism. J. Child. Neurol. 16, 421–424.
Aylward, E. H., Minshew, N. J., Goldstein, G., Honeycutt, N. A., Augustine, A. M., Yates, K. O., Barta, P. E., and Pearlson, G. D. (1999) MRI volumes of amygdala and hippocampus in non-mentally retarded autistic adolescents and adults. Neurology 53, 53.
Saitoh, O., Karns, C. M., and Courchesne, E. (2001) Development of the hippocampal formation from 2 to 42 years: MRI evidence of smaller area dentata in autism. Brain 124, 1317–1324.
Sears, L. L., Vest, C., Mohamed, S., Bailey, J., Ranson, B. J., and Piven, J. (1999) An MRI study of the basal ganglia in autism. Prog. Neuro-Psychopharmacol and Biol. Psychiat. 23, 613–624.
Piven, J., Bailey, B. S., Ranson, B. J., and Arndt, S. (1997) An MRI study fo the corpus callosum in autism. Am. J. Psychiatry 154, 1051–1056.
Casanova, M. F., Buxhoeveden, D. P., Switala, A. E., and Roy, E. (2002) Minicolumnar pathology in autism. Neurology 58, 428–432.
Chan, S., Kwong, K., Hodge, S., McGrath, L., Steele, S., Tager-Flusberg, H., and Harris, G. J. (2002) A voxel-based morphometric study in autism and language impairment. Ann. Neurol. in press.
Courchesne, E., Young-Courchesne, R., Press, G. A., Hesselink, J. R., and Jernigan, T. L. (1988) Hypoplasia of cerebellar vermal lobules VI and VII in autism. New Engl. J. Med. 318, 1349–1354.
Deb, S. and Thompson, B. (1998) Neuroimaging in autism. Br. J. Psychiat. 173, 299–302.
Sultan, F. (2002) Analysis of mammalian brain architecture. Nature 415, 133–134.
Rodier, P. M., Ingram, J. L., Tisdale, B., Nelson, S. and Romano, J. (1996) Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei. J. Comp. Neurol. 370, 247–261.
Ingram, J. L., Stodgell, C. J., Hyman, S. L., Figlewicz, D. A., Weitkamp, L. R., and Rodier, P. M. (2000) Discovery of allelic variants of HOXA1 and HOXB1: genetic susceptibility to autism spectrum disorders. Teratology 62, 393–405.
Hashimoto, T., Tayama, M., Murakawa, K., Yoshimoto, T., Miyazaki, M., Harada, M., and Kuroda, Y. (1995) Development of the brain-stem and cerebellum in autistic patients. J. Autism Develop. Dis. 25, 1–18.
Courchesne, E., Karns, C. M., Davis, H. R., et al. (2001) Unusual brain growth patterns in early life in patients with autistic disorder: an MRI study. Neurology 57, 245–254.
Bolton, P. F. and Griffiths, P. D. (1997) Association of tuberous sclerosis of temporal lobes with autism and atypical autism. Lancet 349, 392–395.
Ballaban-Gil, K. and Tuchman, R. (2000) Epilepsy and epileptiform EEG: association with autism and language disorders. Ment. Retard. Dev. Disabil. Res. Rev. 6, 300–308.
Lewine, J. D., Andrews, R., Chez, M., et al. (1999) Magnetoencephalographic patters of epileptiform activity in children with regressive autism spectrum disorders. Pediatrics 104, 405–418.
Rumsey, J. M., Duara, R., Grady, C., Rapoport, J. L., Margolin, R. A., Rapoport, S. I., and Cutler, N. R. (1985) Brain metabolism in autism. Resting cerebral glucose utilization rates as measured with positron emission tomography. Arch. Gen. Psychiatry 42, 448–455.
Horwitz, B., Rumsey, J. M., Grady, C. L., and Rapoport, S. I. (1988) The cerebral metabolic landscape in autism. Intercorrelations of regional glucose utilization. Arch. Neurol. 45, 749–755.
Asano, E., Chugani, D. C., Muzik, O., Behen, M., Janisse, J., Rothermel, R., Mangner, T. J., Chakraborty, P. K., and Chugani, H. T. (2001) Autism in tuberous sclerosis complex is related to both cortical and subcortical dysfunction. Neurology 57, 1269–1277.
Chugani, D. C., Muzik, O., Behen, M., Rothermel, R., Janisse, J. J., and Chugani, H. T. (1999) Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann. Neurol. 45, 287–295.
Bennett-Clarke, C. A., Chiaia, N. L., Crissman, R. S., and Rhoades, R. W. (1991) The source of the transient serotoninergic input to the developing visual and somatosensory cortices in rat. Neuroscience 43, 163–183.
Lebrand, C., Cases, O., Adelbrecht, C., Doye, A., Alvarez, C., El Mestikawy, S., Seif, I., and Gaspar, P. (1996) Transient uptake and storage of serotonin in developing thalamic neurons. Neuron 17, 823–835.
Goldman-Rakic, P. S. and Brown, R. M. (1982) Postnatal development of monoamine content and synthesis in the cerebral cortex of rhesus monkeys. Dev. Brain Res. 4, 339–349.
Chugani, D. C. (2002) Role of altered brain serotonin mechanisms in autism. Mol. Psychiatry 7 Suppl 2, 16–17.
Huttenlocher, P. R. and Dabholkar, A. S. (1997) Regional differences in synaptogenesis in human cerebral cortex. J. Comp. Neurol. 387, 167–178.
Kemper, T. L. and Bauman, M. L. (1993) The contribution of neuropathologic studies to the understanding of autism. Neurol. Clin. 11, 175–187.
Bailey, A., Luthert, P., Dean, A., Harding, B., Janota, I., Montgomery, M., Rutter, M. and and Lantos, P. (1998) A clinicopathological study of autism. Brain 121, 889–905.
Fatemi, S. H., Halt, A. R., Realmuto, G. R., Earle, J., Kist, D. A., Thuras, P. and Merz, A. (2002) Purkinje cell size reduced in cerebellum of patients with autism. Cell Mol. Neurobiol. 22, 171–175.
Tran, K. D., Smutzer, G. S., Doty, R. L. and Arnold, S. E. (1998) Reduced Purkinje cell size in the cerebellar vermis of elderly patients with schizophrenia. Am. J. Psychiatry 155, 1288–12890.
Bailey, A., Luthert, P., Dean, A., Harding, B., Janota, I., Montgomery, M., Rutter, M. and Lantos, P. (1998) A clinicopathological study of autism. Brain 121, 889–905.
Ahlsen, G., Rosengren, L., Belfrage, M., Palm, A., Haglid, K., Hamberger, A., and Gillberg, C. (1993) Glial fibrillary acid protein in the cerebrospinal fluid of children with autism and other neuropsychiatric disorders. Biol. Psychiatry 33, 734–743.
Nelson, K. B., Grether, J. K., Croen, L. A., Dambrosia, J. M., Dickens, B. F., Jelliffe, L. L., Hansen, R. L., and Phillips, T. M. (2001) Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann. Neurol. 49, 587–606.
Cheng, Y., Tao, Y., Black, I. B., and DiCicco-Bloom, E. (2001) A single peripheral injection of basic fibroblast growth factor (bFGF) stimulates granule cell production and increases cerebellar growth in newborn rats. J. Neurobiol. 46, 220–229.
Ritvo, E. R., Spence, M. A., Freeman, B. J., Mason-Brothers, A., Mo, A., and Marazita, M. L. (1985) Evidence for autosomal recessive inheritance in 46 families with multiple incidences of autism. Evidence for autosomal recessive inheritance in 46 families with multiple incidences of autism. Am. J. Psychiatry 142, 187–192.
Lamb, J. A., Moore, J., Bailey, A., and Monaco, A. P. (2000) Autism: recent molecular genetic advances. Hum. Mol. Genet. 9, 861–868.
Cook, E. H. (2001) Genetics of autism. Child Adolesc. Psychiatr. Clin. N. Am. 10, 333–350.
Wolf, U. (1997) Identical mutations and phenotypic variation. Hum. Genet. 100, 305–321.
Van Slegtenhorst, M., Nellist, M., Nagelkerken, B., et al. (1998) Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. Hum. Mol. Genet. 7, 1053–1057.
Plomin, R. (1999) Genetics and general cognitive ability. Nature 402, C25-C29.
Caviness, V. S. (2001) research strategies in autism: a story with two sides. Curr. Opin. Neurol. 14, 141–143.
Kirov, G., Murphy, K. C., Arranz, M. J., et al. (1998) Low activity allele of catechol-O-methyltransferase gene associated with rapid cycling bipolar disorder. Mol. Psychiatry 3, 342–345.
Schain, R. J. and and Friedman, D. X. (1961) Studies on 5-hydroxyindole metabolism in autistic and other mentally retared children. J. Pediatr. 58, 315–320.
Posey, D. J. and McDougle, C. J. (2001) The pathophysiology and treatment of autism. Curr. Psychiatry Rep. 3, 101–108.
Anderson, G. M., Horne, W. C., Chatterjee, D., and Cohen, D. J. (1990) The hyperserotoninemia of autism. Ann. NY. Acad. Sci. 600, 331–340.
Piven, J., Tsai, G. C., Nehme, E., Coyle, J. T., Chase, G. A., and Folstein, S. E. (1991) Platelet serotonin, a possible marker for familial autism. J. Autism Dev. Disord. 21, 51–59.
Cook, E. H. and Leventhal, B. L. (1996) The serotonin system in autism. Curr. Opin. Pediatr. 8, 348–354.
McBride, P. A., Anderson, G. M., Hertzig, M. E., Snow, M. E., Thompson, S. M., Khait, V. D., Shapiro, T. and Cohen, D. J. (1998) Effects of diagnosis, race, and puberty on platelet serotonin levels in autism and mental retardation. J. Am. Acad. Child Adolesc. Psychiatry 37, 767–776.
Persico, A. M., Pascucci, T., Puglisi-Allegra, S., et al. (2002) Serotonin transporter gene promoter variants do not explain the hyperserotoninemia in autistic children. Mol. Psychiat. 7, 795–800.
Anderson, G. M., Freedman, D. X., Cohen, D. J., et al. (1987) Whole blood serotonin in autistic and normal subjects. J. Child Psychol. Psychiatry 28, 885–900.
Ober, C., Abney, M., and McPeek, M. (2001) The genetic dissection of complex traits in a founder population. Am. J. Hum. Gene. 69, 1068–1079.
Croonenberghs, J., Delmeire, L., Verkerk, R., et al. (2000) Peripheral markers of serotonergic and noradrenergic function in post- pubertal, caucasian males with autistic disorder. Neuropsychopharmacology 22, 275–283.
Marazziti, D., Muratori, F., Cesari, A., Masala, I., Baroni, S., Giannaccini, G., Dell’Osso, L., Cosenza, A., Pfanner, P., and Cassano, G. B. (2000) Increased density of the platelet serotonin transporter in autism. Pharmacopsychiatry 33, 165–168.
Lesch, K. P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., Benjamin, J., Muller, C. R., Hamer, D. H., and Murphy, D. L. (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274, 1527–1531.
Cook, E. H. J., Courchesne, R., Lord, C., Cox, N. J., Yan, S., Lincoln, A., Haas, R., Courchesne, E., and Leventhal, B. L. (1997) Evidence of linkage between the serotonin transporter and autistic disorder. Mol. Psychiatry 2, 247–250.
Klauck, S. M., Poustka, F., Benner, A., Lesch, K. P., and Poutska, A. (1997) Serotonin transporter (5-HTT) gene variants associated with autism? Hum. Mol. Genet. 6, 2233–2238.
Betancur, C., Corbex, M., Spielewoy, C., et al. (2002) Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disorder. Mol. Psychiatry 7, 67–71.
Anderson, G. M., Gutknecht, L., Cohen, D. J., Brailly-Tabard, S., Cohen, J. H., Ferrari, P., Roubertoux, P. L., and Tordjman, S. (2002) Serotonin transporter promoter variants in autism: functional effects and relationship to platelet hyperserotonemia. Mol. Psychiatry 7, 831–836.
Kim, S. J., Cox, N., Courchesne, R., Lord, C., Corsello, C., Akshoomoff, N., Guter, S., Leventhal, B. L., Courchesne, E., and Cook Jr., E. H. (2002) Transmission disequilibrium mapping at the serotonin transporter gene (SLC6A4) region in autistic disorder. Mol. Psychiatry 7, 278–288.
Cases, O., Vitalis, T., Seif, I., De Maeyer, E., Sotelo, C., and Gaspar, P. (1996) Lack of barrels in the somatosensory cortex of monoamine oxidase A- deficient mice: role of a serotonin excess during the critical period. Neuron 16, 297–307.
Persico, A. M., Mengual, E., Moessner, R., et al. (2001) Barrel pattern formation requires serotonin uptake by thalamocortical afferents, and not vesicular monoamine release. J. Neurosci. 21, 6862–6873.
Lo Turco, J. J. and Kriegstein, A. R. (1991) Clusters of coupled neuroblasts in embryonic neocortex. Science 252, 563–566.
Radnikow, G., Feldmeyer, D., and Lubke, J. (2002) Axonal projection, input and output synapses, and synaptic physiology of Cajal-Retzius cells in the developing rat neocortex. J. Neurosci. 22, 6908–6919.
Behar, T. N., Schaffner, A. E., Scott, C. A., O’Connel, C., and Barker, J. L. (1998) Differential Response of Cortical Plate and Ventricular Zone Cells to GABA as a Migration Stimulus. J. Neurosci. 18, 6378–6387.
Behar, T. N., Smith, S. V., Kennedy, R. T., McKenzie, J. M., Maric, I., and Barker, J. L. (2001) GABA(B) receptors mediate motility signals for migrating embryonic cortical cells. Cereb. Cortex 11, 744–753.
Blatt, G. J., Fitzgerald, C. M., Guptill, J. T., Booker, A. B., Kemper, T. L., and Bauman, M. L. (2001) Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study. J. Autism. Dev. Disord. 31, 537–543.
Fatemi, S. H., Halt, A. R., Stary, J. M., Kanodia, R., Schulz, S. C., and Realmuto, G. R. (2002) Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol. Psychiatry 52, 805–810.
Cook, E. H. J., Courchesne, R. Y., Cox, N. J., Lord, C., Gonen, D., Guter, S. J., Lincoln, A., Nix, K., Haas, R., Leventhal, B. L., and Courchesne, E. (1998) Linkage-disequilibrium mapping of autistic disorder, with 15q11-13 markers. Am. J. Hum. Genet. 62, 1077–1083.
Martin, E. R., Menold, M. M., Wolpert, C. M., et al. (2000) Analysis of linkage disequilibrium in gamma-aminobutyric acid receptor subunit genes in autistic disorder. Am. J. Med. Genet. 96, 43–48.
Menold, M. M., Shao, Y., Wolpert, C. M., et al. (2001) Association analysis of chromosome 15 GABAA receptor subunit genes in autistic disorder. J. Neurogenet. 15, 254–249.
Buxbaum, J. D., Silverman, J. M., Smith, C. J., Greenberg, D. A., Kilifarski, M., Reichert, J., Cook, E. H. J., Fang, Y., Song, C. Y., and Vitale, R. (2002) Association between a GABRB3 polymorphism and autism. Mol. Psychiatry 7, 311–316.
Wassink, T. H., Piven, J., Vieland, V. J., Huang, J., Swiderski, R. E., Pietila, J., Braun, T., Beck, G., Folstein, S. E., Haines, J. L., and Sheffield, V. C. (2001) Evidence supporting WNT2 as an autism susceptibility gene. Am. J. Med. Genet. 105, 406–413.
Monkley, S. J., Delaney, S. J., Pennisi, D. J., Christiansen, J. H., and Wainwright, B. J. (1996) Targeted disruption of the Wnt2 gene results in placentation defects. Development 122, 3343–3353.
Lijam, N., Paylor, R., McDonald, M. P., Crawley, J. N., Deng, C. X., Herrup, K., Stevens, K. E., Maccaferri, G., McBain, C. J., Sussman, D. J., and Wynshaw-Boris, A. (1997) Social interaction and sensorimotor gating abnormalities in mice lacking Dv11. Cell 90, 895–905.
Carpenter, E. M., Goddard, J. M., Chisaka, O., Manley, N. R., and Capecchi, M. R. (1993) Loss of Hox-A1 (Hox-1.6) function results in the reorganization of the murine hindbrain. Development 118, 1063–1075.
Mark, M., Lufkin, T., Vonesch, J. L., Ruberte, E., Olivo, J. C., Dolle, P., Gorry, P., Lumsden, A., and Chambon, P. (1993) Two rhombomeres are altered in Hoxa-1 mutant mice. Development 119, 319–338.
Persico, A. M., D’Agruma, L., Maiorano, N., et al. (2001) Reelin gene alleles and haplotypes as a factor predisposing to autistic disorder. Mol. Psychiatry. 6, 150–159.
Pericak-Vance, M. A., personal communication.
Zhang, H., Liu, X., Zhang, C., Mundo, E., Macciardi, F., Grayson, D. R., Guidotti, A. R., and Holden, J. J. R. (2002) Reelin gene alleles and susceptibility fo autism spectrum disorders. Mol. Psychiatry 7, 1012–1017.
Krebs, M. O., Betancur, C., Leroy, S., Bourdel, M. C., Gillberg, C., Leboyer, M., and The Paris Autism Research International Sibpair (PARIS) study. (2002) Absence of association between a polymorphic GGC repeat in the 5′ untranslated region of the reelin gene and autism. Mol. Psychiat. 7, 801–804.
Petek, E., Windpassinger, C., Vincent, J. B., Cheung, J., Boright, A. P., Scherer, S. W., Kroisel, P. M., and Wagner, K. (2001) Disruption of a novel gene (IMMP2L) by a breakpoint in 7q31 associated with Tourette syndrome. Am. J. Hum. Genet. 68, 848–858.
Fatemi, S. H., Stary, J. M., and E. A., E. (2002) Reduced blood levels of reelin as a vulnerability factor in pathophysiology fo autistic disorder. Cell Mol. Neurobiol. 22, 139–152.
D’Arcangelo, G., Miao, G. G., Chen, S. C., Soares, H. D., Morgan, J. I., and Curran, T. (1995) A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature 374, 719–723.
Tueting, P., Costa, E., Dwivedi, Y., Guidotti, A., Impagnatiello, F., Manev, R., and Pesold, C. (1999) The phenotypic characteristics of heterozygous reeler mouse. Neuroreport 10, 1329–1334.
Hadj-Sahraoui, N., Frederic, F., Delhaye-Bouchaud, N., and Mariani, J. (1996) Gender effect on Purkinje cell loss in the cerebellum of the heterozygous reeler mouse. J. Neurogenet. 11, 45–58.
Rice, D. S., Nusinowitz, S., Azimi, A. M., Martinez, A., Soriano, E., and Curran, T. (2001) The Reelin pathway modulates the structure and function of retinal synaptic circuit. Neuron 31, 929–941.
Weeber, E. J., Beffert, U., Jones, C., Christian, J. M., Förster, E., Sweatt, J. D., and Herz, J. (2002) Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning. J. Biol. Chem. 277, 39,944–39,952.
Quattrocchi, C. C., Huang, C., Niu, S., Sheldon, M., Benhayon, D., Cartwright Jr., J., Mosier, D. R., Keller, F., and D’Arcangelo, G. (2003) Reelin promotes peripheral synapse elimination and maturation. Science, in press.
Quattrocchi, C. C., Wannenes, F., Persico, A. M., Ciafré, S. A., D’Arcangelo, G., Farace, M. G., and Keller, F. (2002) Reelin is a serine protease of the extracellular matrix. J. Biol. Chem. 277, 303–309.
Whyatt, R. M. and Barr, D. A. (2001) Measurement of organophosphate metabolites in postpartum meconium as a potential biomarker of prenatal exposure: a validation study. Environm. Health Persp. 109, 417–420.
Fatemi, S. H., Emamian, E. S., Kist, D., Sidwell, R. W., Nakajima, K., Akhter, P., Shier, A., Sheikh, S., and Bailey, K. (1999) Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice. Mol. Psychiatry 4, 145–154.
Insel, T. R. (1997) A neurobiological basis of social attachment. Am. J. Psychiatry 154, 726–735.
Young, L. J., Huot, B., Nilsen, R., Wang, Z., and Insel, T. R. (1996) Species differences in central oxytocin gene expression: comparative analysis of promoter sequences. J. Neuroendocrinol. 8, 777–783.
Winslow, J. T. and Insel, T. R. (2002) The social deficits of the oxytocin knockout mouse. Neuropeptides 36, 221–229.
Green, L., Fein, D., Modahl, C., Feinstein, C., Waterhouse, L., and Morris, M. (2001) Oxytocin and autistic disorder: alterations in peptide forms. Biol. Psychiatry 50, 609–613.
Schroer, R. J., Phelan, M. C., Michaelis, R. C., et al. (1998) Autism and maternally derived aberrations of chromosome 15q. Am. J. Med. Genet. 76, 327–336.
Swaab, D. F., Purba, J. S., and Hofman, M. A. (1995) Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases. J. Clin. Endocrinol. Metab. 80, 573–579.
Lauder, J. M. and Schambra, U. B. (1999) Morphogenetic roles of acetylcholine. Environ. Health Perspect. 107 (Suppl 1), 65–69.
Perry, E. K., Lee, M. L., Martin-Ruiz, C. M., Court, J. A., Volsen, S. G., Merrit, J., Folly, E., Iversen, P. E., Bauman, M. L., Perry, R. H., and Wenk, G. L. (2001) Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. Am. J. Psychiatry. 158, 1058–1066.
Lee, M., Martin-Ruiz, C., Graham, A., Court, J., Jaros, E., Perry, R., Iversen, P., Bauman, M., and Perry, E. (2002) Nicotinic receptor abnormalities in the cerebellar cortex in autism. Brain 125, 1483–1495.
Jones, M. B., Szatmari, P., and Piven, J. (1996) Nonfamiliality of sex ratio in autism. Am. J. Med. Genet. 67, 499–500.
Shao, Y., Wolpert, C. M., Raiford, K. L., et al. (2002) Genomic screen and follow-up analysis for autistic disorder. Am. J. Hum. Genet. 114, 99–105.
Liu, W. S., Pesold, C., Rodriguez, M. A., Carboni, G., Auta, J., Lacor, P., Larson, J., Condie, B. G., Guidotti, A., and Costa, E. (2001) Dwnregulation of dentritic spine and glutamic acid decarboxylase 67 expression in the reelin haploinsufficientheterozygous reeler mouse. Proc. Natl. Acad. Sci. USA 98, 3477–3482.
Jamain, S., Quach, H., Betancur, C., Rastam M., Colineaux, C., Gillberg, I. C., et al. (2003) Paris Autism Research International Sibpair Study. Related Articles, Links Abstract Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat. Genet. 34, 27–29.
Skuse, D. H., James, R. S., Bishop, D. V., Coppin, B., Dalton, P., Aamodt-Leeper, G., Bacarese-Hamilton, M., Creswell, C., McGurk, R., and Jacobs, P. A. (1997) Evidence from Turner’s syndrome of an imprinted X-linked locus affecting cognitive function. Nature 387, 705–708.
Manning, J. T., Baron-Cohen, S., Wheelwright, S., and Sanders, G. (2001) The 2nd to 4th digit ratio and autism. Dev. Med. Child Neurol. 43, 160–164.
Baron-Cohen, S. (2002) The extreme male theory of autism. Trends Cogn. Sci. 6, 248–254.
Doulazmi, M., Frederic, F., Lemaigre-Dubreuil, Y., Hadj-Sahraoui, N., Delhaye-Bouchaud, N., and Mariani, J. (1999) Cerebellar Purkinje cell loss during life span of the heterozygous staggerer mouse (Rora(+)/Rora(sg)) is gender-related. J. Comp. Neurol. 411, 267–273.
Rutter, M. (2000) Genetic studies of autism: from the 1970s into the Millennium. J. Abn. Child Psychol. 28, 3–14.
Plomin, R. and and McGuffin, P. (2003) Psychopathology in the postgenomic era. Ann. Rev. Psychol. 54, 205–228.
Janus, C. and Westaway, D. (2001) Transgenic mouse models of Alzheimer’s disease. Physiology and Behavior 73, 873–886.
Ingram, J. L., Peckham, S. M., Tisdale, B., and Rodier, P. M. (2000) Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. Neurotoxicol. Teratol 22, 319–324.
[No authors listed] (1994) Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian Fragile X Consortium. Cell 78, 23–33.
Nimchinsky, E. A., Oberlander, A. M., and Svoboda, K. (2001) Abnormal development of dendritic spines in FMR1 knock-out mice. J. Neurosci. 21, 5139–5146.
Qin, M., Kang, J. and Smith, C. B. (2002) Increased rates of cerebral glucose metabolism in a mouse model of fragile X mental retardation. Proc. Natl. Acad. Sci. USA 99, 15,758–15,763.
Brainard, M. S. and Doupe, A. J. (2002) What songbirds teach us about lernaning. Nature 417, 351–358.
Leonardo, A. and Konishi, M. (1999) Decrystallization of adult birdsong by perturbation of auditory feedback. Nature 399, 466–470.
Bachevalier, J. (1996) Brief report: medial temporal lobe and autism: a putative animal model in primates. J. Autism Dev. Disord. 26, 217–220.
Prather, M. D., Lavenex, P., Mauldin-Jourdain, M. L., Mason, W. A., Capitanio, J. P., Mendoza, S. P., and Amaral, D. G. (2001) Increased social fear and decreased fear of objects in monkeys with neonatal amygdala lesions. Neuroscience 106, 653–658.
Polanyi, M. (1968) Life’s irreducible structure. Live mechanisms and information in DNA are boundary conditions with a sequence of boundaries above them. Science 160, 1308–1312.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Keller, F., Persico, A.M. The neurobiological context of autism. Mol Neurobiol 28, 1–22 (2003). https://doi.org/10.1385/MN:28:1:1
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/MN:28:1:1